Pricing derivatives when S is risk-neutral but K is real-world
Posted: November 19th, 2024, 1:26 pm
We are busy pricing a derivative (I think!) where the stock price is assumed to follow the usual GBM process. The strike however is not constant and follows a company's EBITDA.
Our theory is that: There is no market for a company's EBITDA and therefore we cannot setup a replicating portfolio. Something along the lines of an incomplete market (I am more than fuzzy on all the technical theory).
At the risk of being scolded I have two questions:
TLDR; I work for "one of the big four" audti firms and the departments are playing hot potato with this valuation. We have previously valued these instruments in the normal risk-neutral fashion but we have a new kid on the block who looked at this and asked the question.
Our theory is that: There is no market for a company's EBITDA and therefore we cannot setup a replicating portfolio. Something along the lines of an incomplete market (I am more than fuzzy on all the technical theory).
At the risk of being scolded I have two questions:
- Is this theory correct and does this mean that we cannot obtain a "risk-neutral" option price?
- If we are forced (by accounting requirements) to "value" this thing, what options (pardon the pun) do we have?
TLDR; I work for "one of the big four" audti firms and the departments are playing hot potato with this valuation. We have previously valued these instruments in the normal risk-neutral fashion but we have a new kid on the block who looked at this and asked the question.